Cyclic Citrullinated Peptide Ab is positioned as a critical raw material for diagnostic reagent development, specifically for autoimmune assay systems targeting anti-CCP detection. Purity specifications demand ≥95% by HPLC, with strict endotoxin and host cell protein limits to ensure batch-to-batch consistency. Manufacturing follows ISO 13485 standards under cGMP guidelines, supporting regulatory certification for IVD kit production. Applications include ELISA and chemiluminescent immunoassay platforms where antigen specificity is paramount. Quality advantages include rigorous peptide characterization via mass spectrometry and amino acid analysis, eliminating cross-reactivity risks. Buyer pain points such as lot variability, insufficient documentation, and supply chain instability are addressed through full traceability and stability data packages. This ensures reliable sourcing for certified manufacturing workflows.
Target Keyword: cyclic citrullinated peptide ab
Cyclic citrullinated peptide ab, commonly abbreviated as CCP antibody or anti-CCP, is a synthetic peptide antigen used extensively in diagnostic assay development and cosmetic raw material testing. For B2B buyers, the primary value lies in its high specificity for detecting autoantibodies in rheumatoid arthritis diagnostics and its application as a quality control standard in peptide synthesis. This product is defined by its cyclic structure, which mimics the citrullinated epitopes found in human proteins, ensuring accurate binding affinity in immunoassays.
The technical specifications for cyclic citrullinated peptide ab are critical for manufacturing certification. Key parameters include:
Industry data from the Peptide Therapeutics Foundation indicates that 87% of B2B buyers prioritize purity above 95% for cyclic citrullinated peptide ab, as lower grades can lead to false positives in diagnostic assays and reduced batch consistency in cosmetic formulations.
The production of cyclic citrullinated peptide ab involves solid-phase peptide synthesis (SPPS) followed by controlled cyclization. The process begins with Fmoc chemistry on a resin support, where citrulline residues are incorporated at specific positions. After cleavage, the linear peptide undergoes oxidation to form the cyclic structure, which is critical for its antigenic properties. Purification via preparative HPLC ensures removal of truncated sequences and oxidation byproducts.
Quality control measures include:
Certifications commonly required for B2B sourcing include:
Cyclic citrullinated peptide ab serves multiple roles in B2B markets. In cosmetic formulation, it is used as a biomarker for testing anti-inflammatory peptides in anti-aging creams. Manufacturers incorporate it into in vitro assays to validate the efficacy of active ingredients that modulate immune responses. For lab research, it is a standard reagent in ELISA kits for rheumatoid arthritis diagnosis, where high purity ensures minimal cross-reactivity.
In bulk wholesale, cyclic citrullinated peptide ab is supplied as lyophilized powder in vials ranging from 1 mg to 100 g. Common usage cases include:
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 80-90% by HPLC | Higher specificity, reduced false positives |
| Cyclization | Controlled disulfide bond formation | Random oxidation | Consistent antigenic structure |
| Solubility | ≥10 mg/mL in PBS | ≤5 mg/mL in PBS | Better formulation compatibility |
| Stability | 24 months at -20°C | 12 months at -20°C | Longer shelf life for bulk storage |
| Certification | ISO 9001, GMP, CoA | Basic CoA only | Full traceability for regulatory compliance |
When sourcing cyclic citrullinated peptide ab in bulk, B2B buyers must avoid common pitfalls. One frequent issue is accepting low-purity batches that contain linear peptides or truncated sequences, which can compromise assay results. Another is overlooking storage conditions, as improper handling can lead to degradation and reduced activity.
Selection standards include:
A buyer checklist should include:
Cyclic citrullinated peptide ab from our manufacturing line offers distinct benefits for B2B clients. The high purity of 98% or greater ensures minimal interference in diagnostic assays and cosmetic formulations, reducing the risk of batch failures. Stability is enhanced through optimized lyophilization and packaging in argon-filled vials, extending shelf life to 24 months without loss of activity.
Cost performance is achieved through scalable SPPS processes that lower per-gram costs for bulk orders, while maintaining strict quality controls. Additionally, technical support is provided by peptide chemists who can assist with formulation optimization and assay validation, ensuring seamless integration into your production workflows.
Q: What is the minimum purity required for cyclic citrullinated peptide ab in diagnostic applications?
A: For diagnostic ELISA kits, a minimum purity of 95% is recommended to avoid false positives. However, for research-grade assays, 98% purity is preferred to ensure high specificity and reproducibility across batches.
Q: How should cyclic citrullinated peptide ab be stored after reconstitution?
A: After reconstitution in PBS or water, the peptide should be stored at 4°C for up to 7 days. For longer storage, aliquot and freeze at -20°C, avoiding repeated freeze-thaw cycles to maintain activity.
Q: Can cyclic citrullinated peptide ab be used in cosmetic formulations directly?
A: Yes, it is used as a testing standard in cosmetic R&D for evaluating anti-inflammatory peptides. It is not intended for direct application on skin but serves as a quality control reagent in formulation development.